PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,930,803 | -11.4% | 2,219,826 | +12.5% | 0.00% | -33.3% |
| Q2 2023 | $25,872,899 | -11.5% | 1,973,524 | -24.5% | 0.00% | 0.0% |
| Q1 2023 | $29,228,667 | +61.2% | 2,614,371 | +21.6% | 0.00% | +50.0% |
| Q4 2022 | $18,128,758 | -41.3% | 2,150,505 | +16.0% | 0.00% | -50.0% |
| Q3 2022 | $30,885,000 | -1.4% | 1,853,823 | -12.9% | 0.00% | 0.0% |
| Q2 2022 | $31,320,000 | +448.6% | 2,127,771 | +824.8% | 0.00% | +300.0% |
| Q1 2022 | $5,709,000 | +165.4% | 230,073 | +243.1% | 0.00% | – |
| Q4 2021 | $2,151,000 | +216.3% | 67,049 | +255.2% | 0.00% | – |
| Q3 2021 | $680,000 | -76.3% | 18,878 | -71.0% | 0.00% | – |
| Q2 2021 | $2,870,000 | +41.0% | 65,036 | +46.1% | 0.00% | – |
| Q1 2021 | $2,036,000 | +108.0% | 44,503 | +213.7% | 0.00% | – |
| Q4 2020 | $979,000 | – | 14,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |